{"nctId":"NCT00910845","briefTitle":"Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence","startDateStruct":{"date":"2009-09"},"conditions":["Overactive Bladder"],"count":557,"armGroups":[{"label":"onabotulinumtoxinA","type":"EXPERIMENTAL","interventionNames":["Biological: onabotulinumtoxinA"]},{"label":"placebo/onabotulinumtoxinA","type":"OTHER","interventionNames":["Biological: onabotulinumtoxinA","Drug: normal saline"]}],"interventions":[{"name":"onabotulinumtoxinA","otherNames":["BOTOXÂ®","botulinum toxin Type A"]},{"name":"normal saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Symptoms of OAB (frequency/urgency) with urinary incontinence for at least 6 months\n* Inadequate response or limiting side effects with anticholinergics for the treatment of OAB\n\nExclusion Criteria:\n\n* Overactive Bladder caused by neurological condition\n* Patient has predominance of stress incontinence\n* History or evidence of pelvic or urological abnormality","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Number of Daily Episodes of Urinary Incontinence","description":"A urinary incontinence episode is defined as an incident of involuntary loss of urine as recorded in a patient bladder diary during the 3 days before the Baseline and Week 12 study visits. A negative number change from baseline indicates a reduction in incontinence episodes (improvement).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.47","spread":"3.621"},{"groupId":"OG001","value":"5.09","spread":"3.204"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.65","spread":"3.333"},{"groupId":"OG001","value":"-0.87","spread":"2.833"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Number of Daily Micturition Episodes","description":"The number of micturition episodes (the number of times a patient urinates into the toilet) was recorded by the patient in a bladder diary during 3 consecutive days in the week prior to the Baseline and prior to the Week 12 study visit. A negative number change from baseline indicates a reduction in micturition episodes (improvement).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.98","spread":"4.259"},{"groupId":"OG001","value":"11.20","spread":"3.070"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.15","spread":"2.933"},{"groupId":"OG001","value":"-0.91","spread":"2.577"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Volume Voided Per Micturition","description":"The total volume voided was measured over one 24-hour period in the week prior to the Baseline and Week 12 study visit and recorded by the patient in the bladder diary. This was used to calculate volume voided per micturition. A positive number change from baseline indicates an increase in volume voided per micturition (improvement).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"156.4","spread":"63.21"},{"groupId":"OG001","value":"161.1","spread":"68.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.1","spread":"87.58"},{"groupId":"OG001","value":"9.7","spread":"59.02"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":18,"n":278},"commonTop":["Urinary tract infection","Dysuria","Bacteriuria","Haematuria","Urinary retention"]}}}